Metoprolol succinate
Metoprolol succinate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Metoprolol succinate; Generic name: METOPROLOL SUCCINATE; Manufacturer: Major Pharmaceuticals.
| Brand name | Metoprolol succinate |
|---|---|
| Generic name | METOPROLOL SUCCINATE |
| Manufacturer | Major Pharmaceuticals |
| Used for | 1 INDICATIONS AND USAGE Metoprolol succinate extended-release tablets are a beta-adrenergic blocker indicated for the treatment of: • Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) • Angina Pectoris. ( 1.2 ) • Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure. ( 1.3) 1.1 Hypertension Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Administer once daily. Titrate at weekly or longer intervals as needed and tolerated. ( 2 ) • Hypertension: Starting dose is 25 to 100 mg. ( 2.1 ) • Angina Pectoris: Starting dose is 100 mg. ( 2.2 ) • Heart Failure: Starting dose is 12.5 or 25 mg. ( 2.3 ) • Switching from immediate-release metoprolol to metoprolol succinate extended-release tablets: use the same total daily dose of metoprolol succinate extended-release tablets. ( 2) 2.1 Hypertension Adults : The usu |
| Active ingredient(s) | METOPROLOL SUCCINATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14ab9921-4651-4abc-92dc-aab1719b6bb0 |